Page results
-
HTD Outpatients offers a wide range of clinics for Chagas disease, Infectious diseases, Leishmaniasis, Leprosy , Malaria , Microbiology, Neglected tropical diseases, Parasitology
-
Information about energy conservation for UCLH patients with mitochondrial disease.
-
Information about the use of deferasirox iron chelation treatment for iron overload.
-
This page has information on how to treat iron overload with Desferrioxamine. It has information on how the medicine is delivered and how you can do it at home.
-
This page provides information on Ulcerative Colitis (UC) and how diet can help you manage any symptoms you are managing, improve wellbeing and support a healthy diet during remission.
-
This page provides information on how diet can help to manage the symptoms of Ulcerative Colitis during a flare up known as active Ulcerative Colitis.
-
Emma, our support and information specialist, gives tips to overcome loneliness.
-
Information about having a gadolinium-based contrast agent for MRI examinations while breastfeeding.
-
Organisations and services offering financial advice to people affected by cancer and blood conditions, and their familes and carers.
-
UCLH has been selected as the lead site in Great Britain for Neuralink’s GB-PRIME study, a clinical investigation for Neuralink’s brain-computer interface (BCI).
File results
-
FOI/2024/0380 - Appraisal review/ Responsible Officer/ Revalidation Officer
-
FOI/2024/0381 - Proton Beam Therapy Centre material use, architectural technology and performance
-
FOI/2024/0385 - Immunoglobulin vials (by brands) distributed to patients
-
FOI/2024/0393 - Translation service/ communication spend
-
FOI/2024/0394 - Private maternity services 2012, 2016, 2018, 2022 and 2023
-
FOI/2024/0395 - Treatment and services for duchenne muscular dystrophy
-
FOI/2024/0400 - Gestational Diabetes Mellitus (GDM) screening and fetal outcomes
-
FOI/2024/0401 - Hospital treatments for abortion complications
-
FOI/2024/0402 - Various IT systems used at the Trust
-
FOI/2024/0403 - Risk Policy and corporate risk register